{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Atomoxetine+hydrochloride", "query": { "intervention": "Atomoxetine hydrochloride" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 128, "total_pages": 13, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Atomoxetine+hydrochloride&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-24T12:58:36.127Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00262470", "title": "Treatment of Orthostatic Intolerance", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Tachycardia", "Chronic Orthostatic Intolerance" ], "interventions": [ { "name": "Acetazolamide", "type": "DRUG" }, { "name": "Atomoxetine", "type": "DRUG" }, { "name": "NO Drug", "type": "OTHER" }, { "name": "Clonidine", "type": "DRUG" }, { "name": "Entacapone", "type": "DRUG" }, { "name": "Entacapone & Propranolol", "type": "DRUG" }, { "name": "Atomoxetine & Propranolol", "type": "DRUG" }, { "name": "Indomethacin", "type": "DRUG" }, { "name": "Mecamylamine", "type": "DRUG" }, { "name": "Isosorbide Dinitrate", "type": "DRUG" }, { "name": "Melatonin", "type": "DIETARY_SUPPLEMENT" }, { "name": "Midodrine", "type": "DRUG" }, { "name": "Modafinil", "type": "DRUG" }, { "name": "Octreotide", "type": "DRUG" }, { "name": "Placebo", "type": "RADIATION" }, { "name": "Propranolol", "type": "DRUG" }, { "name": "Modafinil & Propranolol", "type": "DRUG" }, { "name": "Sertraline", "type": "DRUG" }, { "name": "IV Saline", "type": "PROCEDURE" }, { "name": "Drinking Water", "type": "OTHER" }, { "name": "Breathing Device", "type": "DEVICE" }, { "name": "memantine", "type": "DRUG" }, { "name": "Abdominal binder", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "OTHER", "DIETARY_SUPPLEMENT", "RADIATION", "PROCEDURE", "DEVICE" ], "sponsor": "Satish R. Raj", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 150, "start_date": "1997-04", "completion_date": "2029-12", "has_results": false, "last_update_posted_date": "2025-10-08", "last_synced_at": "2026-09-24T12:58:36.127Z", "location_count": 1, "location_summary": "Nashville, Tennessee", "locations": [ { "city": "Nashville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT00262470" }, { "nct_id": "NCT05933603", "title": "Medications for Obstructive Sleep Apnea to Improve Cognition in Children With Down Syndrome", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Obstructive Sleep Apnea", "Down Syndrome" ], "interventions": [ { "name": "Atomoxetine and Oxybutynin (ato-oxy)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Arizona", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "6 Years to 17 Years" }, "enrollment_count": 36, "start_date": "2023-09-29", "completion_date": "2026-06", "has_results": false, "last_update_posted_date": "2026-04-07", "last_synced_at": "2026-09-24T12:58:36.127Z", "location_count": 1, "location_summary": "Tucson, Arizona", "locations": [ { "city": "Tucson", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT05933603" }, { "nct_id": "NCT07577661", "title": "Combination Upper-Airway Electrical and Pharmacological Stimulation for Obstructive Sleep Apnea", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Obstructive Sleep Apnea", "Sleep-disordered Breathing" ], "interventions": [ { "name": "Combination device and drug: Unilateral hypoglossal nerve stimulation & atomoxetine-plus-oxybutynin (HGNS+AtoOxy)", "type": "OTHER" }, { "name": "Unilateral hypoglossal nerve stimulation (HGNS), active comparator condition", "type": "DEVICE" }, { "name": "Atomoxetine-plus-oxybutynin (80/5 mg) (AtoOxy), active comparator condition", "type": "DRUG" }, { "name": "Placebo; placebo comparator condition", "type": "DRUG" } ], "intervention_types": [ "OTHER", "DEVICE", "DRUG" ], "sponsor": "Brigham and Women's Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "79 Years", "sex": "ALL", "summary": "18 Years to 79 Years" }, "enrollment_count": 24, "start_date": "2026-09-01", "completion_date": "2028-09-01", "has_results": false, "last_update_posted_date": "2026-09-21", "last_synced_at": "2026-09-24T12:58:36.127Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT07577661" }, { "nct_id": "NCT05550246", "title": "Identifying Sleep Apnea Patients That Best Respond to Atomoxetine Plus Oxybutynin Therapy", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Obstructive Sleep Apnea" ], "interventions": [ { "name": "Atomoxetine", "type": "DRUG" }, { "name": "Oxybutynin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Brigham and Women's Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "21 Years to 70 Years" }, "enrollment_count": 22, "start_date": "2022-05-05", "completion_date": "2024-12", "has_results": false, "last_update_posted_date": "2023-10-18", "last_synced_at": "2026-09-24T12:58:36.127Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT05550246" }, { "nct_id": "NCT00183391", "title": "Stimulant Versus Nonstimulant Medication for Attention Deficit Hyperactivity Disorder in Children", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Attention Deficit Disorder With Hyperactivity" ], "interventions": [ { "name": "Atomoxetine", "type": "DRUG" }, { "name": "Methylphenidate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Icahn School of Medicine at Mount Sinai", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "6 Years to 17 Years" }, "enrollment_count": 232, "start_date": "2005-07", "completion_date": "2011-06", "has_results": true, "last_update_posted_date": "2018-06-06", "last_synced_at": "2026-09-24T12:58:36.127Z", "location_count": 2, "location_summary": "Chicago, Illinois • New York, New York", "locations": [ { "city": "Chicago", "state": "Illinois" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00183391" }, { "nct_id": "NCT06400615", "title": "Study That Tests AD109 in Patients Taking GLP-1 Drugs", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "OSA" ], "interventions": [ { "name": "AD109", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Apnimed", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 40, "start_date": "2024-05-20", "completion_date": "2024-12-26", "has_results": false, "last_update_posted_date": "2025-02-19", "last_synced_at": "2026-09-24T12:58:36.127Z", "location_count": 4, "location_summary": "Anniston, Alabama • Jacksonville, Florida • Monroe, North Carolina + 1 more", "locations": [ { "city": "Anniston", "state": "Alabama" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Monroe", "state": "North Carolina" }, { "city": "Memphis", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT06400615" }, { "nct_id": "NCT00607919", "title": "Treatment of ADHD With Atomoxetine in Children & Adolescents With ADHD & Comorbid Dyslexia", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Attention Deficit Hyperactivity Disorder", "Dyslexia" ], "interventions": [ { "name": "Atomoxetine", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "10 Years", "maximum_age": "16 Years", "sex": "ALL", "summary": "10 Years to 16 Years" }, "enrollment_count": 209, "start_date": "2008-03", "completion_date": "2011-02", "has_results": true, "last_update_posted_date": "2011-12-15", "last_synced_at": "2026-09-24T12:58:36.127Z", "location_count": 16, "location_summary": "Irvine, California • Palo Alto, California • San Francisco, California + 13 more", "locations": [ { "city": "Irvine", "state": "California" }, { "city": "Palo Alto", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "New Haven", "state": "Connecticut" }, { "city": "Tampa", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00607919" }, { "nct_id": "NCT00880217", "title": "A Study to Evaluate 3 Different Doses of JNJ-31001074 in the Treatment of Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Attention Deficit Hyperactivity Disorder" ], "interventions": [ { "name": "Atomoxetine 80 mg/d", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "OROS methylphenidate HCl 54 mg/d", "type": "DRUG" }, { "name": "JNJ-31001074 3 mg/d", "type": "DRUG" }, { "name": "JNJ-31001074 1 mg/d", "type": "DRUG" }, { "name": "JNJ-31001074 10 mg/d", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Johnson & Johnson Pharmaceutical Research & Development, L.L.C.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 430, "start_date": "2009-05", "completion_date": "2010-01", "has_results": false, "last_update_posted_date": "2013-03-04", "last_synced_at": "2026-09-24T12:58:36.127Z", "location_count": 35, "location_summary": "Little Rock, Arkansas • Lafayette, California • Los Alamitos, California + 32 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Lafayette", "state": "California" }, { "city": "Los Alamitos", "state": "California" }, { "city": "Santa Ana", "state": "California" }, { "city": "Wildomar", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00880217" }, { "nct_id": "NCT00486122", "title": "Evaluation of Continuous Symptom Treatment of ADHD", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Attention Deficit Hyperactivity Disorder" ], "interventions": [ { "name": "Atomoxetine Hydrochloride", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Years", "maximum_age": "12 Years", "sex": "ALL", "summary": "6 Years to 12 Years" }, "enrollment_count": 282, "start_date": "2003-09", "completion_date": "2004-06", "has_results": false, "last_update_posted_date": "2007-06-13", "last_synced_at": "2026-09-24T12:58:36.127Z", "location_count": 1, "location_summary": "Columbus, Ohio", "locations": [ { "city": "Columbus", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT00486122" }, { "nct_id": "NCT02784535", "title": "Norepinephrine Transporter Blockade, Autonomic Failure (NETAF)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Neurogenic Orthostatic Hypotension" ], "interventions": [ { "name": "Atomoxetine", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Vanderbilt University Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "40 Years to 80 Years" }, "enrollment_count": 48, "start_date": "2016-08-29", "completion_date": "2023-06", "has_results": true, "last_update_posted_date": "2023-09-13", "last_synced_at": "2026-09-24T12:58:36.127Z", "location_count": 2, "location_summary": "New York, New York • Nashville, Tennessee", "locations": [ { "city": "New York", "state": "New York" }, { "city": "Nashville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT02784535" } ] }